These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. DIAZEPAM IN TREATMENT OF EMOTIONAL DISORDERS. LOVE J. Dis Nerv Syst; 1963 Nov; 24():674-7. PubMed ID: 14075333 [No Abstract] [Full Text] [Related]
23. [Tranquilizing therapy: the aspect of the problem from the psychosomatic viewpoint]. DIONIGI R. Riv Sper Freniatr Med Leg Alien Ment; 1961 Mar 31; 85():224-30. PubMed ID: 13886525 [No Abstract] [Full Text] [Related]
24. Effect of chlordiazepoxide on specific symptoms of psychiatric patients and facilitation of psychotherapy. YOCHELSON S. J Clin Exp Psychopathol Q Rev Psychiatry Neurol; 1961 Mar 31; 22():79-88. PubMed ID: 13787332 [No Abstract] [Full Text] [Related]
25. The indications for combined treatment with trifluoperazine and amylobarbitone. WHITELEY JS. Br J Clin Pract; 1961 Jul 31; 15():613-5. PubMed ID: 13784893 [No Abstract] [Full Text] [Related]
28. Psychoneurotic reactions in gynecology and obstetrics. PENA EF. West Med Med J West; 1962 Aug 31; 3():292-5. PubMed ID: 14485046 [No Abstract] [Full Text] [Related]
29. [PSYCHOSOMATIC RESEARCH OF MIGRAINE]. IMAI T. Fukuoka Igaku Zasshi; 1963 Aug 31; 54():895-912. PubMed ID: 14087537 [No Abstract] [Full Text] [Related]
30. [CLINICAL STUDY OF VALNOCTAMIDE ON 70 NEUROPSYCHIATRIC CLINIC PATIENTS UNDERGOING AMBULATORY TREATMENT]. HARL FM. Presse Med (1893); 1964 Mar 14; 72():753-4. PubMed ID: 14119722 [No Abstract] [Full Text] [Related]
31. [Combined hypnosis and trifluoperazine treatment in psychosomatic disorders]. HELOU HA. Dia Med; 1962 Jun 07; 34():951-2. PubMed ID: 13906349 [No Abstract] [Full Text] [Related]
32. SOME ASPECTS OF ADVANCES IN PSYCHIATRY. TAN ES. Med J Malaya; 1963 Sep 07; 18():30-7. PubMed ID: 14064294 [No Abstract] [Full Text] [Related]
33. Therapy of psychosomatic symptoms in gynecology, an evaluation of chlordiazepoxide. MOORE SF. Curr Ther Res Clin Exp; 1962 May 07; 4():249-57. PubMed ID: 14475720 [No Abstract] [Full Text] [Related]
34. [SYMPOSIUM ON PSYCHOSOMATIC MEDICINE AND INTERNAL MEDICINE. (6) INTERNAL DISEASES]. KOGA Y. Nihon Naika Gakkai Zasshi; 1963 Dec 10; 52():1013-8. PubMed ID: 14158035 [No Abstract] [Full Text] [Related]
35. [NEUROTIC DEFENSE AND SYMPTOMATOLOGY]. HAU TF. Z Psychother Med Psychol; 1964 Jul 10; 14():148-52. PubMed ID: 14178329 [No Abstract] [Full Text] [Related]
36. THE USE OF QUESTIONNAIRES IN PERSONALITY MEASUREMENT IN PSYCHOSOMATIC RESEARCH. KISSEN DM. J Psychosom Res; 1964 Dec 10; 8():293-6. PubMed ID: 14242399 [No Abstract] [Full Text] [Related]
37. [Value of psychodiagnostic tests in a borderline case between psychasthenia and schizophrenia]. MILANI B. G Psichiatr Neuropatol; 1961 Dec 10; 89():1311-43. PubMed ID: 14473806 [No Abstract] [Full Text] [Related]
38. A POSSIBLE EFFECT OF SELECTION ON THE TEST SCORES OF A GROUP OF HYPERTENSIVES. ROBINSON JO. J Psychosom Res; 1964 Dec 10; 8():239-43. PubMed ID: 14242393 [No Abstract] [Full Text] [Related]
39. Neurotic repetition and general practitioner psychotherapy. SANDERS K. J Coll Gen Pract; 1962 Feb 10; 5(1):66-71. PubMed ID: 14496821 [No Abstract] [Full Text] [Related]
40. [Trials with a new mental tensiolytic agent in general practice: "Control-OM"]. ROSSIER M. Praxis; 1962 Mar 15; 51():291-3. PubMed ID: 14494309 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]